Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158236 · ClinicalTrials.gov registry record · NA
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00158236 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 7 participants.
The verdict
NCT00158236, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Buprenorphine is a medication used to treat opioid addiction, but individuals who use this drug are at risk of abusing it. A buprenorphine and naloxone combination may reduce the likelihood of buprenorphine addiction. This study will evaluate the potential for abuse of buprenorphine and a buprenorphine and naloxone combination in non-dependent opioid users.
Interventions
- DRUG Hydromorphone
- DRUG Buprenorphine
- DRUG Buprenorphine and Naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 1997-01 |
| Est. Completion | 1998-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158236
The ClinicalTrials.gov registry entry for NCT00158236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Hydromorphone is the first listed.
NCT00158236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158236 about?
NCT00158236 is a clinical study titled "Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users". Buprenorphine is a medication used to treat opioid addiction, but individuals who use this drug are at risk of abusing it. A buprenorphine and naloxone combination may reduce the likelihood of buprenorphine addiction. This study will evaluate the potential for abuse of buprenorphine and a buprenorph...
What is the current status of trial NCT00158236?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 1997-01. Estimated completion is 1998-03.
What interventions are being tested in trial NCT00158236?
The interventions under investigation include: Hydromorphone (DRUG), Buprenorphine (DRUG), Buprenorphine and Naloxone (DRUG).
Who is sponsoring clinical trial NCT00158236?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.